INTERNATIONAL PATENT: SFJ PHARMA X, INC. FILES APPLICATION FOR "METHODS OF REVERSING TICAGRELOR ACTIVITY"

GENEVA, Jan. 27 -- SFJ PHARMA X, INC. (5000 Hopyard Road, suite 330Pleasanton, California 94588) filed a patent application (PCT/US2025/037799) for "METHODS OF REVERSING TICAGRELOR ACTIVITY" on Jul 15, 2025. With publication no. WO/2026/019858, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WHITE, Barbara A. (7830 Ellenham RoadTowson, Maryland 21204)

Abstract: Herein is provided a method of reversing ticagrelor-enhanced bleeding in a patient comprising administering to said patient during surgery, in a perioperative set...